10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2015 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net Sales | $ 20,405 | 20,247 | 19,657 |
| Cost of products sold, excluding amortization of intangible assets | 8,747 | 9,218 | 9,193 |
| Amortization of intangible assets | 601 | 555 | 588 |
| Research and development | 1,405 | 1,345 | 1,371 |
| Selling, general and administrative | 6,785 | 6,530 | 6,372 |
| Total operating cost and expenses | 17,538 | 17,648 | 17,524 |
| Operating earnings | 2,867 | 2,599 | 2,133 |
| Interest expense | 163 | 150 | 145 |
| Interest income | (105) | (77) | (67) |
| Net loss on extinguishment of debt | 18 | ||
| Net foreign exchange (gain) loss | (93) | (24) | 46 |
| Other (income) expense, net | (281) | 14 | (32) |
| Earnings from Continuing Operations Before Taxes | 3,183 | 2,518 | 2,041 |
| Taxes on Earnings from Continuing Operations | 577 | 797 | 53 |
| Earnings from continuing operations | 2,606 | 1,721 | 1,988 |
| Earnings from Discontinued Operations, net of taxes | 65 | 563 | 588 |
| Gain on sale of Discontinued Operations, net of taxes | 1,752 | ||
| Net Earnings from Discontinued Operations, net of taxes | 1,817 | 563 | 588 |
| Net Earnings | 4,423 | 2,284 | 2,576 |
| Basic Earnings Per Common Share - | |||
| Continuing Operations (in dollars per share) | 1.73 | 1.13 | 1.27 |
| Discontinued Operations (in dollars per share) | 1.21 | 0.37 | 0.37 |
| Net Earnings (in dollars per share) | 2.94 | 1.50 | 1.64 |
| Diluted Earnings Per Common Share - | |||
| Continuing Operations (in dollars per share) | 1.72 | 1.12 | 1.26 |
| Discontinued Operations (in dollars per share) | 1.20 | 0.37 | 0.36 |
| Net Earnings (in dollars per share) | 2.92 | 1.49 | 1.62 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,496 | 1,516 | 1,558 |
| Dilutive Common Stock Options (in shares) | 10 | 11 | 16 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,506 | 1,527 | 1,574 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 1 | 1 | 1 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |